Question
Since the ReSound Verso Invisible-In-the-Canal (IIC) is obviously very small, how many typical patients are candidates? In other words, what is the fit rate or candidacy rate?
Answer
In the field study we conducted prior to launch, we took a sample of 250 subjects and found that 96% were candidates for Verso. One of our goals in introducing the IIC was to offer a product that could fit more patients than comparable products on the market. What we heard was that these really could only fit a small number of patients who were interested in them, so we focused on a few key design factors to drive greater candidacy yield. We designed a new faceplate that utilizes a battery pill rather than a flex strip, since the flex contacts will add bulk to a faceplate. We’ve also been able to eliminate a few components within the instrument that also reduces the overall dimension. In addition, we reduced the shell thickness, which gave us more real estate on the interior, and enabled us to further recess the device. We spent a lot of time with our R&D engineering group as we developed the manufacturing process to make sure that the Verso IIC is robust and has as much mechanical integrity as any other custom hearing instrument from ReSound.
For more information about ReSound Verso IIC, please refer to the complete interview on AudiologyOnline, or visit www.resound.com/verso or the ReSound Expo Page on AudiologyOnline.
